The survey was done at the department of Surgical Sciences, recruiting patients candidate to surgery for any thyroid disease from January 2013 to April 2014. Criteria of exclusion were substernal ...

Analyst Ratings Published 05/27/2025, 06:20 AM 0 BTIG cuts Globus Medical stock rating to neutral, removes PT GMED 0.61% ...

STAT has gathered and analyzed various sources of publicly available health data to establish a baseline of chronic disease in the U.S. Finding timely and complete data on the prevalence and costs ...

4. Thyroid Disease Some people who see a healthcare provider for globus sensations are diagnosed with a thyroid disorder. Thyroid disease is found in up to a third of all people who describe the ...

In San Francisco, Globus Choice participants can trek through Muir Woods to admire towering redwood trees and drive through the seaside town of Sausalito. Food enthusiasts might prefer a culinary tour ...

Amid his ongoing battle with Charcot-Marie-Tooth disease, Alan Jackson performed at the Grand Ole Opry's 100-year live concert celebration. Jackson was diagnosed with the disease in 2011, which ...

The renowned medical device company has a market capitalization of $9.92 billion. Globus Medical has an earnings yield of 4.78%, well ahead of the industry’s -2.56% yield.

Globus specifically has over 33 different itineraries for Italy, spanning over 90 cities. Q: What about on the rivers with Avalon? A: We're about 75% sold for 2025, which is fantastic.

Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 6.6% year on year to $657.3 million. The company expects ...

Graves’ disease can affect your mental health in several ways, and it’s important to consider talking with your doctor if you have any feelings of sadness, anxiety, nervousness, or ...

The exact cause of Alzheimer’s disease has long evaded scientists, but experts typically suggest there are likely several factors (like genetics, environment, and lifestyle) that contribute to ...

With Globus paying $5.85 for each of Nevro’s outstanding shares, that amounts to a 27% premium over a 90-day weighted average, or a 38% bonus over the past 30-odd days.